{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T06:57:52Z","timestamp":1780642672667,"version":"3.54.1"},"reference-count":140,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Myeloid neoplasms (MNs) with germline predisposition represent a distinct, increasingly recognized category in the WHO classification, encompassing myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) arising in the context of an inherited genetic alteration or mutation. While often presenting at a younger age or with characteristic cytopenias with or without organ dysfunction, some can manifest in adulthood, highlighting the need for vigilance regardless of age or family history. Key predisposing genes include transcription factors (e.g., RUNX1, CEBPA) and genes involved in RNA splicing and telomere biology disorders. Identification of these germline mutations is critical as MNs with germline predisposition dictate specific therapeutic strategies\u2014particularly for hematopoietic stem cell transplantation (HSCT)\u2014and require genetic counseling and surveillance for at-risk relatives. Accurate diagnosis often requires non-hematopoietic germline DNA testing, which provides important biological insights into the development of different myeloid neoplasms and directs personalized patient care.<\/jats:p>","DOI":"10.3390\/cancers18020240","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T08:17:32Z","timestamp":1768292252000},"page":"240","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Moving Beyond Somatic Alterations: Uncovering the Germline Basis of Myeloid Malignancies"],"prefix":"10.3390","volume":"18","author":[{"given":"Ismail","family":"Elbaz Younes","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2614-1306","authenticated-orcid":false,"given":"Lynh","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Pathology and Laboratory Medicine, James A. Haley Veterans\u2019 Hospital, Tampa, FL 33612, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1463-1458","authenticated-orcid":false,"given":"Ling","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pathology, H. Lee Moffitt Cancer Center, Tampa, FL 33612, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Bochicchio, M.T., Micucci, G., Asioli, S., Ghetti, M., Simonetti, G., and Lucchesi, A. (2023). Germline CSF3R Variant in Chronic Myelomonocytic Leukemia: Linking Genetic Predisposition to Uncommon Hemorrhagic Symptoms. Int. J. Mol. Sci., 24.","DOI":"10.20944\/preprints202309.1533.v1"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: Integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"ref_4","unstructured":"Swerdlow, S.H., Campo, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., Stein, H., Thiele, J., and Vardiman, J.W. (2008). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, International Agency for Research on Cancer."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/13793","article-title":"Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia","volume":"23","author":"Song","year":"1999","journal-title":"Nat. Genet."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/1042819031000139611","article-title":"Familial mutations of the transcription factor RUNX1 (AML1, CBFA2) predispose to acute myeloid leukemia","volume":"45","author":"Ganly","year":"2004","journal-title":"Leuk. Lymphoma"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/ajcp\/aqad075","article-title":"How I diagnose myeloid neoplasms with germline predisposition","volume":"160","author":"Patel","year":"2023","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e432218","DOI":"10.1200\/EDBK_432218","article-title":"Germline Predisposition in Hematologic Malignancies: Testing, Management, and Implications","volume":"44","author":"Godley","year":"2024","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1182\/blood-2015-04-641100","article-title":"Genomic analysis of germ line and somatic variants in familial myelodysplasia\/acute myeloid leukemia","volume":"126","author":"Churpek","year":"2015","journal-title":"Blood"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1053\/j.seminhematol.2017.04.001","article-title":"Familial CEBPA-mutated acute myeloid leukemia","volume":"54","author":"Tawana","year":"2017","journal-title":"Semin. Hematol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1053\/j.seminhematol.2017.04.007","article-title":"DDX41-related myeloid neoplasia","volume":"54","author":"Maciejewski","year":"2017","journal-title":"Semin. Hematol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s12185-017-2260-y","article-title":"Myeloid neoplasms with germline DDX41 mutation","volume":"106","author":"Cheah","year":"2017","journal-title":"Int. J. Hematol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"a003210","DOI":"10.1101\/mcs.a003210","article-title":"Hematologic malignancies and Li-Fraumeni syndrome","volume":"5","author":"Swaminathan","year":"2019","journal-title":"Cold Spring Harb. Mol. Case Stud."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1210\/me.2010-0318","article-title":"CCAAT\/enhancer-binding proteins (C\/EBP)-\u03b1 and -\u03b2 are essential for ovulation, luteinization, and the expression of key target genes","volume":"25","author":"Fan","year":"2011","journal-title":"Mol. Endocrinol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s004410100420","article-title":"Mice lacking CCAAt\/enhancer-binding protein-\u03b1 show hyperproliferation of alveolar type II cells and increased surfactant protein mRNAs","volume":"306","author":"Sugahara","year":"2001","journal-title":"Cell Tissue Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/bbrc.1998.8999","article-title":"Hepatocytes deficient in CCAAT\/enhancer binding protein \u03b1 (C\/EBP \u03b1) exhibit both hepatocyte and biliary epithelial cell character","volume":"249","author":"Tomizawa","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1073\/pnas.94.2.569","article-title":"Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein \u03b1-deficient mice","volume":"94","author":"Zhang","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.immuni.2004.11.006","article-title":"Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C\/EBP \u03b1","volume":"21","author":"Zhang","year":"2004","journal-title":"Immunity"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e2315659121","DOI":"10.1073\/pnas.2315659121","article-title":"Transcription factor C\/EBP\u03b1 is required for the development of Ly6C(hi) monocytes but not Ly6C(lo) monocytes","volume":"121","author":"Kim","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/leu.2013.273","article-title":"The role of different genetic subtypes of CEBPA mutated AML","volume":"28","author":"Fasan","year":"2014","journal-title":"Leukemia"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1093\/jnci\/60.6.1243","article-title":"Thirteen cases of leukemia in a family","volume":"60","author":"Gunz","year":"1978","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1365-2141.2010.08204.x","article-title":"Poor prognosis in familial acute myeloid leukaemia with combined biallelic CEBPA mutations and downstream events affecting the ATM, FLT3 and CDX2 genes","volume":"150","author":"Carmichael","year":"2010","journal-title":"Br. J. Haematol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1056\/NEJMoa041331","article-title":"Mutation of CEBPA in familial acute myeloid leukemia","volume":"351","author":"Smith","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1182\/blood-2010-09-307280","article-title":"Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: Further evidence for CEBPA double mutant AML as a distinctive disease entity","volume":"117","author":"Taskesen","year":"2011","journal-title":"Blood"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1182\/blood-2015-05-647172","article-title":"Disease evolution and outcomes in familial AML with germline CEBPA mutations","volume":"126","author":"Tawana","year":"2015","journal-title":"Blood"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1200\/JCO.2008.16.5563","article-title":"Somatic CEBPA mutations are a frequent second event in families with germline CEBPA mutations and familial acute myeloid leukemia","volume":"26","author":"Pabst","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1042\/BST20230725","article-title":"DDX41: Exploring the roles of a versatile helicase","volume":"52","author":"Winstone","year":"2024","journal-title":"Biochem. Soc. Trans."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1534\/genetics.119.302973","article-title":"Insights into the Involvement of Spliceosomal Mutations in Myelodysplastic Disorders from Analysis of SACY-1\/DDX41 in Caenorhabditis elegans","volume":"214","author":"Tsukamoto","year":"2020","journal-title":"Genetics"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.ccell.2015.03.017","article-title":"Inherited and Somatic Defects in DDX41 in Myeloid Neoplasms","volume":"27","author":"Polprasert","year":"2015","journal-title":"Cancer Cell"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nature10738","article-title":"Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing","volume":"481","author":"Ding","year":"2012","journal-title":"Nature"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/leu.2017.44","article-title":"Donor cell leukemia arising from preleukemic clones with a novel germline DDX41 mutation after allogenic hematopoietic stem cell transplantation","volume":"31","author":"Kobayashi","year":"2017","journal-title":"Leukemia"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/leu.2016.310","article-title":"Re-emergence of acute myeloid leukemia in donor cells following allogeneic transplantation in a family with a germline DDX41 mutation","volume":"31","author":"Berger","year":"2017","journal-title":"Leukemia"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1182\/blood.2021015135","article-title":"The genetic landscape of germline DDX41 variants predisposing to myeloid neoplasms","volume":"140","author":"Li","year":"2022","journal-title":"Blood"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/PAI.0000000000001215","article-title":"Peripheral Blood and Bone Marrow Findings in Treatment-Naive Patients With Cytopenia(s)\/Myeloid Neoplasms Harboring Both a Germline and a Somatic DDX41 Mutation","volume":"32","author":"Bruehl","year":"2024","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1182\/blood-2015-10-676098","article-title":"Novel germ line DDX41 mutations define families with a lower age of MDS\/AML onset and lymphoid malignancies","volume":"127","author":"Lewinsohn","year":"2016","journal-title":"Blood"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Bannon, S.A., Routbort, M.J., Montalban-Bravo, G., Mehta, R.S., Jelloul, F.Z., Takahashi, K., Daver, N., Oran, B., Pemmaraju, N., and Borthakur, G. (2020). Next-Generation Sequencing of DDX41 in Myeloid Neoplasms Leads to Increased Detection of Germline Alterations. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.582213"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1182\/blood.2022018221","article-title":"Germ line DDX41 mutations define a unique subtype of myeloid neoplasms","volume":"141","author":"Makishima","year":"2023","journal-title":"Blood"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/ajh.25486","article-title":"DDX41 mutations in myeloid neoplasms are associated with male gender, TP53 mutations and high-risk disease","volume":"94","author":"Quesada","year":"2019","journal-title":"Am. J. Hematol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3324\/haematol.2020.270553","article-title":"Unique ethnic features of DDX41 mutations in patients with idiopathic cytopenia of undetermined significance, myelodysplastic syndrome, or acute myeloid leukemia","volume":"107","author":"Choi","year":"2022","journal-title":"Haematologica"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/s41375-021-01404-0","article-title":"AML with germline DDX41 variants is a clinicopathologically distinct entity with an indolent clinical course and favorable outcome","volume":"36","author":"Li","year":"2022","journal-title":"Leukemia"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.2021015328","article-title":"Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: An ALFA-FILO study","volume":"140","author":"Duployez","year":"2022","journal-title":"Blood"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1182\/blood.2019000909","article-title":"Germline DDX41 mutations define a significant entity within adult MDS\/AML patients","volume":"134","author":"Sebert","year":"2019","journal-title":"Blood"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJMoa061292","article-title":"Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion","volume":"355","author":"List","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1038\/leu.2016.228","article-title":"Molecular predictors of response in patients with myeloid neoplasms treated with lenalidomide","volume":"30","author":"Negoro","year":"2016","journal-title":"Leukemia"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ajh.25610","article-title":"Successful lenalidomide treatment in high risk myelodysplastic syndrome with germline DDX41 mutation","volume":"95","author":"Kantarjian","year":"2020","journal-title":"Am. J. Hematol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Voskarides, K., and Giannopoulou, N. (2023). The Role of TP53 in Adaptation and Evolution. Cells, 12.","DOI":"10.3390\/cells12030512"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"747","DOI":"10.7326\/0003-4819-71-4-747","article-title":"Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?","volume":"71","author":"Li","year":"1969","journal-title":"Ann. Intern. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1126\/science.1978757","article-title":"Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms","volume":"250","author":"Malkin","year":"1990","journal-title":"Science"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1001\/jamaoncol.2021.4398","article-title":"Analysis of the Li-Fraumeni Spectrum Based on an International Germline TP53 Variant Data Set: An International Agency for Research on Cancer TP53 Database Analysis","volume":"7","author":"Kratz","year":"2021","journal-title":"JAMA Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1200\/JCO.2014.59.5728","article-title":"Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers","volume":"33","author":"Bougeard","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_52","first-page":"5358","article-title":"A cancer family syndrome in twenty-four kindreds","volume":"48","author":"Li","year":"1988","journal-title":"Cancer Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1200\/JCO.2009.22.7967","article-title":"2009 version of the Chompret criteria for Li Fraumeni syndrome","volume":"27","author":"Tinat","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/CCO.0000000000000423","article-title":"Revisiting tumor patterns and penetrance in germline TP53 mutation carriers: Temporal phases of Li-Fraumeni syndrome","volume":"30","author":"Amadou","year":"2018","journal-title":"Curr. Opin. Oncol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"111296","DOI":"10.1016\/j.isci.2024.111296","article-title":"Clustering of TP53 variants into functional classes correlates with cancer risk and identifies different phenotypes of Li-Fraumeni syndrome","volume":"27","author":"Montellier","year":"2024","journal-title":"iScience"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.canlet.2005.12.039","article-title":"The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families","volume":"245","author":"Achatz","year":"2007","journal-title":"Cancer Lett."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1158\/2159-8290.CD-22-1315","article-title":"An African-Specific Variant of TP53 Reveals PADI4 as a Regulator of p53-Mediated Tumor Suppression","volume":"13","author":"Indeglia","year":"2023","journal-title":"Cancer Discov."},{"key":"ref_58","unstructured":"Adam, M.P., Feldman, J., Mirzaa, G.M., Pagon, R.A., Wallace, S.E., and Amemiya, A. (1993). ETV6-Related Thrombocytopenia and Predisposition to Leukemia. GeneReviews\u00ae, University of Washington."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.mayocp.2019.12.013","article-title":"Hereditary Predisposition to Hematopoietic Neoplasms: When Bloodline Matters for Blood Cancers","volume":"95","author":"Mangaonkar","year":"2020","journal-title":"Mayo Clin. Proc."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.beha.2019.05.001","article-title":"Hereditary myeloid malignancies","volume":"32","author":"Rafei","year":"2019","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/ijlh.12999","article-title":"Inherited thrombocytopenia and platelet disorders with germline predisposition to myeloid neoplasia","volume":"41","author":"Galera","year":"2019","journal-title":"Int. J. Lab. Hematol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.stem.2015.06.002","article-title":"Runx1 Deficiency Decreases Ribosome Biogenesis and Confers Stress Resistance to Hematopoietic Stem and Progenitor Cells","volume":"17","author":"Cai","year":"2015","journal-title":"Cell Stem Cell"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1182\/blood-2016-10-687830","article-title":"Role of RUNX1 in hematological malignancies","volume":"129","author":"Sood","year":"2017","journal-title":"Blood"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1182\/blood.V99.4.1364","article-title":"In vitro analyses of known and novel RUNX1\/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: Implications for mechanisms of pathogenesis","volume":"99","author":"Michaud","year":"2002","journal-title":"Blood"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Forster, A., Decker, M., Schlegelberger, B., and Ripperger, T. (2022). Beyond Pathogenic RUNX1 Germline Variants: The Spectrum of Somatic Alterations in RUNX1-Familial Platelet Disorder with Predisposition to Hematologic Malignancies. Cancers, 14.","DOI":"10.3390\/cancers14143431"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.3324\/haematol.2021.278762","article-title":"The RUNX1 database (RUNX1db): Establishment of an expert curated RUNX1 registry and genomics database as a public resource for familial platelet disorder with myeloid malignancy","volume":"106","author":"Homan","year":"2021","journal-title":"Haematologica"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1182\/bloodadvances.2019000644","article-title":"ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants","volume":"3","author":"Luo","year":"2019","journal-title":"Blood Adv."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1182\/bloodadvances.2023011165","article-title":"Genomic landscape of patients with germline RUNX1 variants and familial platelet disorder with myeloid malignancy","volume":"8","author":"Yu","year":"2024","journal-title":"Blood Adv."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1182\/bloodadvances.2021004653","article-title":"B-cell acute lymphoblastic leukemia in patients with germline RUNX1 mutations","volume":"5","author":"Six","year":"2021","journal-title":"Blood Adv."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1182\/bloodadvances.2019000901","article-title":"RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML","volume":"4","author":"Brown","year":"2020","journal-title":"Blood Adv."},{"key":"ref_71","unstructured":"Adam, M.P., Feldman, J., Mirzaa, G.M., Pagon, R.A., Wallace, S.E., and Amemiya, A. (1993). ANKRD26-Related Thrombocytopenia. GeneReviews\u00ae, University of Washington."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"113939","DOI":"10.1016\/j.celrep.2024.113939","article-title":"Ankrd26 is a retinoic acid-responsive plasma membrane-binding and -shaping protein critical for proper cell differentiation","volume":"43","author":"Englisch","year":"2024","journal-title":"Cell Rep."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1172\/JCI71861","article-title":"Thrombocytopenia-associated mutations in the ANKRD26 regulatory region induce MAPK hyperactivation","volume":"124","author":"Bluteau","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1086\/302637","article-title":"An autosomal dominant thrombocytopenia gene maps to chromosomal region 10p","volume":"65","author":"Savoia","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000071812","article-title":"FLJ14813 missense mutation: A candidate for autosomal dominant thrombocytopenia on human chromosome 10","volume":"55","author":"Gandhi","year":"2003","journal-title":"Hum. Hered."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1111\/j.1538-7836.2010.03979.x","article-title":"A mutation in the acyl-coenzyme A binding domain-containing protein 5 gene (ACBD5) identified in autosomal dominant thrombocytopenia","volume":"8","author":"Punzo","year":"2010","journal-title":"J. Thromb. Haemost."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ajhg.2010.12.006","article-title":"Mutations in the 5\u2019 UTR of ANKRD26, the ankirin repeat domain 26 gene, cause an autosomal-dominant form of inherited thrombocytopenia, THC2","volume":"88","author":"Pippucci","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11899-022-00666-4","article-title":"ANKRD26-Related Thrombocytopenia and Predisposition to Myeloid Neoplasms","volume":"17","author":"Sullivan","year":"2022","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1080\/09537104.2016.1267337","article-title":"Spectrum of 5\u2019UTR mutations in ANKRD26 gene in patients with inherited thrombocytopenia: C.-140C>G mutation is more frequent than expected","volume":"28","author":"Ferrari","year":"2017","journal-title":"Platelets"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"6673","DOI":"10.1182\/blood-2011-02-336537","article-title":"Mutations in ANKRD26 are responsible for a frequent form of inherited thrombocytopenia: Analysis of 78 patients from 21 families","volume":"117","author":"Noris","year":"2011","journal-title":"Blood"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"5708","DOI":"10.1182\/blood-2024-208018","article-title":"Expanding the Morphologic Spectrum of ANKRD26-Related Thrombocytopenia-2: A Case Series","volume":"144","author":"Wahlster","year":"2024","journal-title":"Blood"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1182\/blood-2013-03-489344","article-title":"A missense mutation in ANKRD26 segregates with thrombocytopenia","volume":"122","author":"Housawi","year":"2013","journal-title":"Blood"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e20210444","DOI":"10.1084\/jem.20210444","article-title":"Familial thrombocytopenia due to a complex structural variant resulting in a WAC-ANKRD26 fusion transcript","volume":"218","author":"Wahlster","year":"2021","journal-title":"J. Exp. Med."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Dell\u2019Orso, G., Passarella, T., Cappato, S., Cappelli, E., Regis, S., Maffei, M., Balbi, M., Ravera, S., Di Martino, D., and Viaggi, S. (2025). Chromosomal Deletion Involving ANKRD26 Leads to Expression of a Fusion Protein Responsible for ANKRD26-Related Thrombocytopenia. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26157330"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"259","DOI":"10.5482\/ha12050001","article-title":"Inherited thrombocytopenias: The evolving spectrum","volume":"32","author":"Balduini","year":"2012","journal-title":"Hamostaseologie"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1182\/blood-2013-04-499319","article-title":"ANKRD26-related thrombocytopenia and myeloid malignancies","volume":"122","author":"Noris","year":"2013","journal-title":"Blood"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1080\/09537104.2022.2071853","article-title":"Prevalence and natural history of variants in the ANKRD26 gene: A short review and update of reported cases","volume":"33","author":"Vyas","year":"2022","journal-title":"Platelets"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1101\/gad.1239604","article-title":"Tel\/Etv6 is an essential and selective regulator of adult hematopoietic stem cell survival","volume":"18","author":"Hock","year":"2004","journal-title":"Genes Dev."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/S1470-2045(15)00369-1","article-title":"Germline genetic variation in ETV6 and risk of childhood acute lymphoblastic leukaemia: A systematic genetic study","volume":"16","author":"Moriyama","year":"2015","journal-title":"Lancet Oncol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/ng.3253","article-title":"Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia","volume":"47","author":"Noetzli","year":"2015","journal-title":"Nat. Genet."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1182\/blood.2019852418","article-title":"ETV6-related thrombocytopenia and leukemia predisposition","volume":"134","author":"Porter","year":"2019","journal-title":"Blood"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1182\/blood.2020006164","article-title":"Molecular basis of ETV6-mediated predisposition to childhood acute lymphoblastic leukemia","volume":"137","author":"Nishii","year":"2021","journal-title":"Blood"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"104725","DOI":"10.1016\/j.ejmg.2023.104725","article-title":"Functional damaging germline variants in ETV6, IKZF1, PAX5 and RUNX1 predisposing to B-cell precursor acute lymphoblastic leukemia","volume":"66","author":"Wagener","year":"2023","journal-title":"Eur. J. Med. Genet."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/humu.24271","article-title":"GATA2 deficiency syndrome: A decade of discovery","volume":"42","author":"Homan","year":"2021","journal-title":"Hum. Mutat."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"101197","DOI":"10.1016\/j.beha.2020.101197","article-title":"Germline predisposition in myeloid neoplasms: Unique genetic and clinical features of GATA2 deficiency and SAMD9\/SAMD9L syndromes","volume":"33","author":"Sahoo","year":"2020","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"ref_96","first-page":"PO-18","article-title":"Germline Genetic Predisposition to Myeloid Neoplasia From GATA2 Gene Mutations: Lessons Learned From Two Cases","volume":"3","author":"Bannon","year":"2019","journal-title":"JCO Precis. Oncol."},{"key":"ref_97","unstructured":"Garofola, C., Nassereddin, A., and Gross, G.P. (2025). Dyskeratosis Congenita. StatPearls, StatPearls Publishing."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"101282","DOI":"10.1016\/j.beha.2021.101282","article-title":"Treatment of telomeropathies","volume":"34","author":"Vieri","year":"2021","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/gim.2016.23","article-title":"Low risk of solid tumors in persons with Down syndrome","volume":"18","author":"Hasle","year":"2016","journal-title":"Genet. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MOP.0b013e3280128ce8","article-title":"Myelodysplastic and myeloproliferative disorders in children","volume":"19","author":"Hasle","year":"2007","journal-title":"Curr. Opin. Pediatr."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1470-2045(00)00435-6","article-title":"Pattern of malignant disorders in individuals with Down\u2019s syndrome","volume":"2","author":"Hasle","year":"2001","journal-title":"Lancet Oncol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(99)05264-2","article-title":"Risks of leukaemia and solid tumours in individuals with Down\u2019s syndrome","volume":"355","author":"Hasle","year":"2000","journal-title":"Lancet"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1182\/blood-2011-11-394221","article-title":"Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: A Children\u2019s Oncology Group study","volume":"119","author":"Chen","year":"2012","journal-title":"Blood"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1182\/blood.2025029250","article-title":"Clinical significance of preleukemic somatic GATA1 mutations in children with Down syndrome","volume":"146","author":"Elliott","year":"2025","journal-title":"Blood"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Peroni, E., Gottardi, M., D\u2019Antona, L., Randi, M.L., Rosato, A., and Coltro, G. (2023). Hematologic Neoplasms Associated with Down Syndrome: Cellular and Molecular Heterogeneity of the Diseases. Int. J. Mol. Sci., 24.","DOI":"10.20944\/preprints202309.1589.v1"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.3324\/haematol.2023.283225","article-title":"Down syndrome and leukemia: From basic mechanisms to clinical advances","volume":"108","author":"Baruchel","year":"2023","journal-title":"Haematologica"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"e2116550119","DOI":"10.1073\/pnas.2116550119","article-title":"Structure and function of an effector domain in antiviral factors and tumor suppressors SAMD9 and SAMD9L","volume":"119","author":"Peng","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1086\/508069","article-title":"A deleterious mutation in SAMD9 causes normophosphatemic familial tumoral calcinosis","volume":"79","author":"Topaz","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/sj.jid.5701203","article-title":"Normophosphatemic familial tumoral calcinosis is caused by deleterious mutations in SAMD9, encoding a TNF-\u03b1 responsive protein","volume":"128","author":"Chefetz","year":"2008","journal-title":"J. Investig. Dermatol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/ng.3569","article-title":"SAMD9 mutations cause a novel multisystem disorder, MIRAGE syndrome, and are associated with loss of chromosome 7","volume":"48","author":"Narumi","year":"2016","journal-title":"Nat. Genet."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1172\/JCI91913","article-title":"Somatic mutations and progressive monosomy modify SAMD9-related phenotypes in humans","volume":"127","author":"Buonocore","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Roucher-Boulez, F., Mallet, D., Chatron, N., Dijoud, F., Gorduza, D.B., Bretones, P., and Morel, Y. (2019). Reversion SAMD9 Mutations Modifying Phenotypic Expression of MIRAGE Syndrome and Allowing Inheritance in a Usually de novo Disorder. Front. Endocrinol., 10.","DOI":"10.3389\/fendo.2019.00625"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1182\/blood-2018-99-118389","article-title":"SAMD9 and SAMD9L Germline Disorders in Patients Enrolled in Studies of the European Working Group of MDS in Childhood (EWOG-MDS): Prevalence, Outcome, Phenotype and Functional Characterisation","volume":"132","author":"Sahoo","year":"2018","journal-title":"Blood"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1038\/s41467-017-01590-5","article-title":"The genomic landscape of pediatric myelodysplastic syndromes","volume":"8","author":"Schwartz","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1182\/blood-2017-09-806489","article-title":"A landscape of germ line mutations in a cohort of inherited bone marrow failure patients","volume":"131","author":"Bluteau","year":"2018","journal-title":"Blood"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Suntharalingham, J.P., Ishida, M., Del Valle, I., Stalman, S.E., Solanky, N., Wakeling, E., Moore, G.E., Achermann, J.C., and Buonocore, F. (2022). Emerging phenotypes linked to variants in SAMD9 and MIRAGE syndrome. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.953707"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"e15283","DOI":"10.1111\/ped.15283","article-title":"Discovery of MIRAGE syndrome","volume":"64","author":"Narumi","year":"2022","journal-title":"Pediatr. Int."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1182\/blood.2022017717","article-title":"Genetic and clinical spectrum of SAMD9 and SAMD9L syndromes: From variant interpretation to patient management","volume":"145","author":"Sahoo","year":"2025","journal-title":"Blood"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1038\/s41591-021-01511-6","article-title":"Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9\/SAMD9L syndromes","volume":"27","author":"Sahoo","year":"2021","journal-title":"Nat. Med."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"5712","DOI":"10.1182\/blood-2024-208398","article-title":"Spontaneous Regression of Monosomy 7 Clone in a Premature Infant with RECQL4-Associated Syndrome","volume":"144","author":"Reed","year":"2024","journal-title":"Blood"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3324\/haematol.2023.283591","article-title":"Spontaneous remission and loss of monosomy 7: A window of opportunity for young children with SAMD9L syndrome","volume":"109","author":"Erlacher","year":"2024","journal-title":"Haematologica"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1182\/blood-2017-05-787390","article-title":"Germline loss-of-function SAMD9 and SAMD9L alterations in adult myelodysplastic syndromes","volume":"132","author":"Nagata","year":"2018","journal-title":"Blood"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1038\/leu.2017.142","article-title":"Germline SAMD9 mutation in siblings with monosomy 7 and myelodysplastic syndrome","volume":"31","author":"Schwartz","year":"2017","journal-title":"Leukemia"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"e121086","DOI":"10.1172\/jci.insight.121086","article-title":"Germline SAMD9 and SAMD9L mutations are associated with extensive genetic evolution and diverse hematologic outcomes","volume":"3","author":"Wong","year":"2018","journal-title":"JCI Insight"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"e20201195","DOI":"10.1084\/jem.20201195","article-title":"Germline SAMD9L truncation variants trigger global translational repression","volume":"218","author":"Allenspach","year":"2021","journal-title":"J. Exp. Med."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/0002-9343(78)90744-1","article-title":"A family with acute leukemia, hypoplastic anemia and cerebellar ataxia: Association with bone marrow C-monosomy","volume":"65","author":"Li","year":"1978","journal-title":"Am. J. Med."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"e318","DOI":"10.3324\/haematol.2018.207316","article-title":"A novel germline SAMD9L mutation in a family with ataxia-pancytopenia syndrome and pediatric acute lymphoblastic leukemia","volume":"104","author":"Cheah","year":"2019","journal-title":"Haematologica"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.ajhg.2016.04.009","article-title":"Ataxia-Pancytopenia Syndrome Is Caused by Missense Mutations in SAMD9L","volume":"98","author":"Chen","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1182\/blood-2016-10-743302","article-title":"Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms","volume":"129","author":"Tesi","year":"2017","journal-title":"Blood"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"104217","DOI":"10.1016\/j.exphem.2024.104217","article-title":"Of gains and losses: SAMD9\/SAMD9L and monosomy 7 in myelodysplastic syndrome","volume":"134","author":"Cammenga","year":"2024","journal-title":"Exp. Hematol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1182\/blood.2022019304","article-title":"Prevalence and clinical expression of germ line predisposition to myeloid neoplasms in adults with marrow hypocellularity","volume":"142","author":"Molteni","year":"2023","journal-title":"Blood"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"e2110190118","DOI":"10.1073\/pnas.2110190118","article-title":"SAMD9L autoinflammatory or ataxia pancytopenia disease mutations activate cell-autonomous translational repression","volume":"118","author":"Russell","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1089\/gte.1998.2.293","article-title":"High frequency of a common Bloom syndrome Ashkenazi mutation among Jews of Polish origin","volume":"2","author":"Shomrat","year":"1998","journal-title":"Genet. Test."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"iyaf005","DOI":"10.1093\/genetics\/iyaf005","article-title":"Functions of the Bloom syndrome helicase N-terminal intrinsically disordered region","volume":"229","author":"Bereda","year":"2025","journal-title":"Genetics"},{"key":"ref_135","unstructured":"Hafsi, W., Badri, T., and Rice, A.S. (2025). Bloom Syndrome. StatPearls, StatPearls Publishing."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"7968","DOI":"10.1073\/pnas.89.17.7968","article-title":"Elevated sister chromatid exchange phenotype of Bloom syndrome cells is complemented by human chromosome 15","volume":"89","author":"McDaniel","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00428-022-03447-9","article-title":"The International Consensus Classification (ICC) of hematologic neoplasms with germline predisposition, pediatric myelodysplastic syndrome, and juvenile myelomonocytic leukemia","volume":"482","author":"Rudelius","year":"2023","journal-title":"Virchows Arch."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1146\/annurev-pathmechdis-111523-023420","article-title":"Inherited Predispositions to Myeloid Neoplasms: Pathogenesis and Clinical Implications","volume":"20","author":"Liu","year":"2025","journal-title":"Annu. Rev. Pathol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1182\/bloodadvances.2020002013","article-title":"Heterozygous germ line CSF3R variants as risk alleles for development of hematologic malignancies","volume":"4","author":"Trottier","year":"2020","journal-title":"Blood Adv."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Elbaz Younes, I., Mroz, P., Tashakori, M., Hamed, A., and Sen, S. (2025). Chronic Neutrophilic Leukemia: Advances in Diagnosis, Genetic Insights, and Management Strategies. Cancers, 17.","DOI":"10.3390\/cancers17020227"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/2\/240\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T08:29:37Z","timestamp":1768292977000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/2\/240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":140,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["cancers18020240"],"URL":"https:\/\/doi.org\/10.3390\/cancers18020240","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,13]]}}}